Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Long-Term Debt Repayments (2016 - 2024)

Orthopediatrics (KIDS) has disclosed Long-Term Debt Repayments for 7 consecutive years, with $11.3 million as the latest value for Q3 2024.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $11.3 million in Q3 2024 year-over-year; TTM through Dec 2025 was $11.7 million, a 4.4% decrease, with the full-year FY2024 number at $12.2 million, changed N/A from a year prior.
  • Long-Term Debt Repayments was $11.3 million for Q3 2024 at Orthopediatrics, up from $390000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $11.3 million in Q3 2024 to a low of -$102000.0 in Q4 2022.
  • A 3-year average of $1.1 million and a median of $34000.0 in 2022 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 154.69% in 2022; the steepest drop was 177.86% in 2022.
  • Orthopediatrics' Long-Term Debt Repayments stood at $131000.0 in 2021, then tumbled by 177.86% to -$102000.0 in 2022, then skyrocketed by 11181.37% to $11.3 million in 2024.
  • Per Business Quant, the three most recent readings for KIDS's Long-Term Debt Repayments are $11.3 million (Q3 2024), $390000.0 (Q2 2024), and $538000.0 (Q1 2024).